Sun L, Lv Y, Li D, Feng J, Chen Z, Lin L
Integr Cancer Ther. 2024; 23:15347354241291514.
PMID: 39427265
PMC: 11503713.
DOI: 10.1177/15347354241291514.
Ege E, Briggi D, Vu P, Cheng J, Lin F, Xu J
Ther Adv Neurol Disord. 2024; 17:17562864241252718.
PMID: 39318973
PMC: 11421407.
DOI: 10.1177/17562864241252718.
Matsumura Y, Futagami M, Baba T, Soeda S, Watari H, Terada Y
Integr Cancer Ther. 2024; 23:15347354241278635.
PMID: 39256982
PMC: 11403691.
DOI: 10.1177/15347354241278635.
Masocha W, Aly E, Albaloushi A, Al-Romaiyan A
Biomedicines. 2024; 12(7).
PMID: 39062118
PMC: 11274467.
DOI: 10.3390/biomedicines12071545.
Saracoglu I, Isintas M, Turk A, Leysen L, Nijs J
Support Care Cancer. 2024; 32(6):383.
PMID: 38801531
PMC: 11130012.
DOI: 10.1007/s00520-024-08594-0.
Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
Shalaby N, Zaki H, Badary O, Kamal S, Nagy M, Makhlouf D
Asian Pac J Cancer Prev. 2024; 25(4):1391-1409.
PMID: 38680001
PMC: 11162739.
DOI: 10.31557/APJCP.2024.25.4.1391.
Knockdown siRNA Targeting GPR55 Reveals Significant Differences Between the Anti-inflammatory Actions of KLS-13019 and Cannabidiol.
Brenneman D, Kinney W, McDonnell M, Ippolito M, Ward S
J Mol Neurosci. 2024; 74(2):41.
PMID: 38602576
DOI: 10.1007/s12031-024-02217-3.
Knockdown siRNA targeting GPR55 reveals significant differences between the anti-inflammatory actions of KLS-13019 and cannabidiol.
Brenneman D, Kinney W, McDonnell M, Ippolito M, Ward S
Res Sq. 2024; .
PMID: 38464007
PMC: 10925471.
DOI: 10.21203/rs.3.rs-3982851/v1.
Anticancer therapy-induced adverse drug reactions in children and preventive and control measures.
Yan H, Wang P, Yang F, Cheng W, Chen C, Zhai B
Front Pharmacol. 2024; 15:1329220.
PMID: 38425652
PMC: 10902428.
DOI: 10.3389/fphar.2024.1329220.
Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
Parsons S, Rodday A, Pei Q, Keller F, Wu Y, Henderson T
J Patient Rep Outcomes. 2023; 7(1):113.
PMID: 37947987
PMC: 10638179.
DOI: 10.1186/s41687-023-00653-0.
Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding.
Alwhaibi A, Alshamrani A, Alenazi M, Altwalah S, Alameel N, Aljabali N
J Clin Med. 2023; 12(17).
PMID: 37685729
PMC: 10488791.
DOI: 10.3390/jcm12175662.
Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Cao A, Cartmel B, Li F, Gottlieb L, Harrigan M, Ligibel J
JAMA Netw Open. 2023; 6(8):e2326463.
PMID: 37526937
PMC: 10394582.
DOI: 10.1001/jamanetworkopen.2023.26463.
Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain.
Farkas D, Inan S, Heydari L, Johnson C, Zhao P, Bradshaw H
Life Sci. 2023; 328:121878.
PMID: 37392779
PMC: 10527577.
DOI: 10.1016/j.lfs.2023.121878.
Efficacy of a rehabilitation program using minor muscles in colorectal cancer patients with chemotherapy-induced neuropathy: preliminary study.
Hong K, Chung S, Kim K, Lee R
Korean J Clin Oncol. 2023; 18(1):11-16.
PMID: 36945329
PMC: 9942769.
DOI: 10.14216/kjco.22002.
IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON THE QUALITY OF LIFE IN CANCER PATIENTS.
Novak M, Milicevic J, Bisof V
Acta Clin Croat. 2022; 61(1):52-61.
PMID: 36530966
PMC: 9753526.
DOI: 10.20471/acc.2022.61.01.07.
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
Schlesinger T, Stockfleth E, Grada A, Berman B
Clin Cosmet Investig Dermatol. 2022; 15:2495-2506.
PMID: 36415541
PMC: 9675993.
DOI: 10.2147/CCID.S374122.
Mindfulness is associated with severity of peripheral neuropathy and related patient-reported outcomes among colorectal cancer patients.
Bonhof C, van de Poll-Franse L, de Hingh I, Vreugdenhil G, Mols F
Support Care Cancer. 2022; 30(11):9517-9526.
PMID: 36030458
PMC: 9633463.
DOI: 10.1007/s00520-022-07340-8.
Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures.
Brenneman D, Kinney W, McDonnell M, Zhao P, Abood M, Ward S
J Mol Neurosci. 2022; 72(9):1859-1874.
PMID: 35779192
PMC: 9398971.
DOI: 10.1007/s12031-022-02038-2.
Periodontal ligament stem cells as a promising therapeutic target for neural damage.
Mohebichamkhorami F, Fattahi R, Niknam Z, Aliashrafi M, Naeimi S, Gilanchi S
Stem Cell Res Ther. 2022; 13(1):273.
PMID: 35729595
PMC: 9210648.
DOI: 10.1186/s13287-022-02942-9.
Comparison of Clinical Symptoms and Neurophysiological Findings in Patients With Chemotherapy Induced Peripheral Neuropathy.
Cho K, Han E, Shin J, Ha M, Ahn K, Cho S
Front Neurol. 2022; 13:838302.
PMID: 35720059
PMC: 9198442.
DOI: 10.3389/fneur.2022.838302.